U.S. Brand Names:
Vasocon-A® [OTC]
Synonyms:
Antazoline and Naphazoline
Generic Available:
No
Canadian Brand Names:
Albalon®-A Liquifilm; Vasocon-A®
Use:
Topical ocular congestion, irritation and itching
Pregnancy Risk Factor:
C
Contraindications:
Hypersensitivity to naphazoline, antazoline, or any component of the formulation; angle-closure glaucoma
Adverse Reactions:
Frequency not defined.
Cardiovascular: Systemic cardiovascular stimulation, hypertension
Central nervous system: Nervousness, dizziness, headache
Gastrointestinal: Nausea
Local: Transient stinging
Neuromuscular & skeletal: Weakness
Ocular: Mydriasis, increased intraocular pressure, blurred vision
Respiratory: Nasal mucosa irritation, dryness, rebound congestion
Miscellaneous: Diaphoresis
Drug Interactions:
MAO inhibitors (exaggerated adrenergic effects may result)
Stability:
Store in tight, light-resistant containers
Dosage:
Ophthalmic: 1-2 drops every 3-4 hours
Patient Education:
Do not use discolored solutions
Nursing Implications:
Do not use discolored solutions
Dental Health: Effects on Dental Treatment:
No significant effects or complications reported
Dental Health: Vasoconstrictor/Local Anesthetic Precautions:
No information available to require special precautions
Mental Health: Effects on Mental Status:
May cause nervousness or dizziness
Mental Health: Effects on Psychiatric Treatment:
TCAs and MAO inhibitors may potentiate the pressor response of decongestants; monitor for changes in response
Dosage Forms:
Solution, ophthalmic: Naphazoline hydrochloride 0.05% and antazoline phosphate 0.5% (15 mL) [contains benzalkonium chloride]
International Brand Names:
Albalon®-A Liquifilm (CA); Vasocon-A® (CA)